[go: up one dir, main page]

MXPA03005914A - Moduladores de canales de sodio derivados de 2-piperidimidazoles. - Google Patents

Moduladores de canales de sodio derivados de 2-piperidimidazoles.

Info

Publication number
MXPA03005914A
MXPA03005914A MXPA03005914A MXPA03005914A MXPA03005914A MX PA03005914 A MXPA03005914 A MX PA03005914A MX PA03005914 A MXPA03005914 A MX PA03005914A MX PA03005914 A MXPA03005914 A MX PA03005914A MX PA03005914 A MXPA03005914 A MX PA03005914A
Authority
MX
Mexico
Prior art keywords
piperidylimidazoles
sodium channel
channel modulators
modulators derived
derived
Prior art date
Application number
MXPA03005914A
Other languages
English (en)
Inventor
Bigg Dennis
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of MXPA03005914A publication Critical patent/MXPA03005914A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA03005914A 2000-12-28 2001-12-27 Moduladores de canales de sodio derivados de 2-piperidimidazoles. MXPA03005914A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017149A FR2818978B1 (fr) 2000-12-28 2000-12-28 Modulateurs de canaux sodiques derives de 2-piperidylimidazoles
PCT/FR2001/004209 WO2002053559A1 (fr) 2000-12-28 2001-12-27 Modulateurs de canaux sodiques derives de 2-piperidylimidazoles

Publications (1)

Publication Number Publication Date
MXPA03005914A true MXPA03005914A (es) 2003-09-10

Family

ID=8858291

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005914A MXPA03005914A (es) 2000-12-28 2001-12-27 Moduladores de canales de sodio derivados de 2-piperidimidazoles.

Country Status (24)

Country Link
US (1) US20040077640A1 (es)
EP (1) EP1349850B1 (es)
JP (1) JP2004517121A (es)
KR (1) KR100892656B1 (es)
CN (1) CN1214025C (es)
AR (1) AR035613A1 (es)
AT (1) ATE304005T1 (es)
AU (1) AU2002228128B8 (es)
BR (1) BR0116581A (es)
CA (1) CA2432959A1 (es)
CZ (1) CZ20032053A3 (es)
DE (1) DE60113297T2 (es)
DK (1) DK1349850T3 (es)
ES (1) ES2249488T3 (es)
FR (1) FR2818978B1 (es)
HU (1) HUP0600032A2 (es)
IL (1) IL156352A0 (es)
MX (1) MXPA03005914A (es)
NO (1) NO20032904D0 (es)
NZ (1) NZ526394A (es)
PL (1) PL363640A1 (es)
RU (1) RU2275369C2 (es)
WO (1) WO2002053559A1 (es)
ZA (1) ZA200305005B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008001596A (ja) * 2004-09-03 2008-01-10 Astellas Pharma Inc ナトリウムチャネル阻害剤
BRPI0620239B8 (pt) * 2005-12-22 2021-05-25 Newron Pharm Spa derivados de 2-feniletilamino.
CA2647603A1 (en) 2006-03-27 2007-10-04 Toray Industries, Inc. Ureide derivative and use thereof for medical purposes
DE102007047243A1 (de) 2007-09-25 2009-04-02 Karl Storz Gmbh & Co. Kg Bipolares medizinisches Instrument
BRPI0905759A2 (pt) * 2008-01-25 2015-07-14 Du Pont Composto selecionado a partir dos compostos de fórmula 1 e n óxidos e sais dos mesmos, método para controlar doenças de planta causadas por patógenos de planta fúngicos oomycota e composição fungicida
WO2025122832A1 (en) * 2023-12-07 2025-06-12 Genep Inc. Imidazole compounds and their use as sodium channel inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07509219A (ja) * 1992-04-01 1995-10-12 ザ ユニバーシティー オブ トレド H↓3受容体アンタゴニストとしての4−[4’−ピペリジニルまたは3’−ピロリジニル]置換イミダゾールおよび治療上のその使用方法
US5296609A (en) * 1993-04-09 1994-03-22 Syntex Pharmaceuticals, Ltd. Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
EP0793653A1 (en) * 1994-11-23 1997-09-10 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
ATE433446T1 (de) * 1995-10-06 2009-06-15 Merck & Co Inc Substituierte imidazole mit krebsremmender und cytokininhibierender wirkung
EP0906307B1 (en) * 1996-06-10 2005-04-27 Merck & Co., Inc. Substituted imidazoles having cytokine inhibitory activity
AU761020B2 (en) * 1998-06-12 2003-05-29 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Beta-carboline compounds
BR0009322A (pt) * 1999-03-26 2002-04-30 Euro Celtique Sa Pirazóis, imidazóis, oxazóis, tiazóis e pirróis substituìdos com arila e o uso dos mesmos
US6297256B1 (en) * 1999-06-15 2001-10-02 Neurogen Corporation Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
HK1045503A1 (zh) * 1999-12-16 2002-11-29 Schering Corporation 取代的咪唑神经肽yy5受体拮抗物

Also Published As

Publication number Publication date
DE60113297T2 (de) 2006-07-13
FR2818978A1 (fr) 2002-07-05
AU2002228128B2 (en) 2006-08-03
ZA200305005B (en) 2004-06-28
EP1349850A1 (fr) 2003-10-08
PL363640A1 (en) 2004-11-29
KR100892656B1 (ko) 2009-04-15
BR0116581A (pt) 2004-01-06
EP1349850B1 (fr) 2005-09-07
CA2432959A1 (fr) 2002-07-11
WO2002053559A1 (fr) 2002-07-11
FR2818978B1 (fr) 2003-02-28
DE60113297D1 (de) 2005-10-13
NO20032904L (no) 2003-06-24
NZ526394A (en) 2004-12-24
CZ20032053A3 (en) 2004-04-14
RU2003123119A (ru) 2005-01-10
HK1059784A1 (en) 2004-07-16
IL156352A0 (en) 2004-01-04
AU2002228128B8 (en) 2007-01-04
KR20030070592A (ko) 2003-08-30
HUP0600032A2 (en) 2006-06-28
ES2249488T3 (es) 2006-04-01
DK1349850T3 (da) 2006-01-23
RU2275369C2 (ru) 2006-04-27
NO20032904D0 (no) 2003-06-24
AU2002228128A1 (en) 2002-07-16
AR035613A1 (es) 2004-06-16
CN1483029A (zh) 2004-03-17
JP2004517121A (ja) 2004-06-10
ATE304005T1 (de) 2005-09-15
CN1214025C (zh) 2005-08-10
US20040077640A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2001286965A1 (en) Sodium channel modulators
MXPA03002410A (es) 4-amino-quinazolinas.
ZA200207270B (en) Sealing system.
ZA200205479B (en) Novel biarylcarboxamides.
ZA200107739B (en) Common packet channel.
MXPA03005445A (es) Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c.
ZA200210206B (en) Expression system.
ZA200007669B (en) Insert.
EG23262A (en) Delta -pyrrolines.
AU2002236775A1 (en) Sodium channel modulators
MXPA03003532A (es) Antibacterianos de cetolida.
MXPA03001591A (es) Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
GB0020532D0 (en) Channel member
MXPA03001877A (es) 2-guanidin-4-arilquinazolinas.
MXPA03002668A (es) Guanidinas de sulfonilo.
MXPA03001991A (es) Novedosas arilalcano-sulfonamidas.
MXPA03002411A (es) 4-amino-quinazolinas.
MXPA03005714A (es) Sulfamidotienopirimidinas.
AU1480002A (en) An improved seal
MXPA03005494A (es) Benzoilpiridazinas.
MXPA03005914A (es) Moduladores de canales de sodio derivados de 2-piperidimidazoles.
MXPA03002521A (es) Triazol-epotilona.
MXPA01000464A (es) Composicion.
MXPA03005217A (es) Dispositivos para aplicar un parche.
GB0002612D0 (en) C.m.e

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status